Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Topotecan for CNS Metastases
NCT01736800Phase 2Withdrawn
- Sponsor
- Houston Methodist Research Institute
- Start
- Mar 2007
- Primary completion
- Nov 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, topotecan liposome in central nervous system metastases, sponsored by Houston Methodist Research Institute. Planned start Mar 2007; status: withdrawn.
02
Drugs
temozolomidetopotecan liposome
03
Conditions
central nervous system metastases
Beyond the preview
Go deeper on NCT01736800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736800.